Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2

Biochemical and Biophysical Research Communications

Volumn 388, Issue 1, 2009, Pages 73-78

  Kim, Jaehyung ^a   Kim, Sung Jin ^b   Lee, Heuiran ^b   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

GABA; GAD65; Neuropathic pain; rAAV2; Sciatic nerve

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOVIRUS VECTOR; GLUTAMATE DECARBOXYLASE 65; PROTEIN C FOS;

4 AMINOBUTYRIC ACID RELEASE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; GENE TRANSFER; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SPINAL CORD; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLUTAMATE DECARBOXYLASE; MALE; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 68949150754     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.120     Document Type: Article

References (41)

1. Bridges D., Thompson S.W., and Rice A.S. Mechanisms of neuropathic pain. Br. J. Anaesthesiol. 87 (2001) 12-26
2. Campbell J.N., and Meyer R.A. Mechanisms of neuropathic pain. Neuron 52 (2006) 77-92
3. Christensen M.D., Everhart A.W., Pickelman J.T., and Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain 68 (1996) 97-107
4. Finnerup N.B., Sindrup S.H., and Jensen T.S. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam. Clin. Pharmacol. 21 (2007) 129-136
5. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
6. Stoyanova II. Gamma-aminobutyric acid immunostaining in trigeminal, nodose and spinal ganglia of the cat. Acta Histochem. 106 (2004) 309-314
7. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
8. Feldblum S., Dumoulin A., Anoal M., Sandillon F., and Privat A. Comparative distribution of GAD65 and GAD67 mRNAs and proteins in the rat spinal cord supports a differential regulation of these two glutamate decarboxylases in vivo. J. Neurosci. Res. 42 (1995) 742-757
9. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 19 (1998) 500-505
10. Mi J., Chatterjee S., Wong K.K., Forbes C., Lawless G., and Tobin A.J. Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J. Neurosci. Res. 57 (1999) 137-148
11. Castro-Lopes J.M., Tavares I., and Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res. 620 (1993) 287-291
12. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22 (2002) 6724-6731
13. Liu J., Wolfe D., Hao S., Huang S., Glorioso J.C., Mata M., and Fink D.J. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol. Ther. 10 (2004) 57-66
14. Beutler A.S., and Reinhardt M. AAV for pain: steps towards clinical translation. Gene Ther. 16 (2009) 461-469
15. Grieger J.C., and Samulski R.J. Adeno-associated virus as a gene therapy vector: vector development. Adv. Biochem. Eng. Biotechnol. 99 (2005) 119-145
16. McCarty D.M. Self-complementary AAV vectors; advances and applications. Mol. Ther. 16 (2008) 1648-1656
17. Lee B., Lee H., Nam Y.R., Oh J.H., Cho Y.H., and Chang J.W. Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther. 12 (2005) 1215-1222
18. Lee B., Kim J., Kim S.J., Lee H., and Chang J.W. Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain. Biochem. Biophys. Res. Commun. 357 (2007) 971-976
19. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
20. Lee B.H., Won R., Baik E.J., Lee S.H., and Moon C.H. An animal model of neuropathic pain employing injury to the sciatic nerve branches. Neuroreport 11 (2000) 657-661
21. Gu Y., Xu Y., Li G.W., and Huang L.Y. Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine. J. Pain 6 (2005) 447-454
22. Hogan Q., Sapunar D., Modric-Jednacak K., and McCallum J.B. Detection of neuropathic pain in a rat model of peripheral nerve injury. Anesthesiology 101 (2004) 476-487
23. Catheline G., Le Guen S., and Besson J.M. Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study. Pain 92 (2001) 389-398
24. Hao S., Mata M., Wolfe D., Huang S., Glorioso J.C., and Fink D.J. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann. Neurol. 57 (2005) 914-918
25. Martin M.E., and Rice K.G. Peptide-guided gene delivery. AAPS J. 9 (2007) E18-E29
26. Seow Y., and Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol. Ther. 17 (2009) 767-777
27. Tenenbaum L., Chtarto A., Lehtonen E., Velu T., Brotchi J., and Levivier M. Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6 Suppl. 1 (2004) S212-S222
28. Burger C., Nash K., and Mandel R.J. Recombinant adeno-associated viral vectors in the nervous system. Hum. Gene Ther. 16 (2005) 781-791
29. Lu Y. Recombinant adeno-associated virus as delivery vector for gene therapy - a review. Stem Cells Dev. 13 (2004) 133-145
30. Monahan P.E., and Samulski R.J. AAV vectors: is clinical success on the horizon?. Gene Ther. 7 (2000) 24-30
31. Mueller C., and Flotte T.R. Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther. 15 (2008) 858-863
32. Goss J.R., Goins W.F., Lacomis D., Mata M., Glorioso J.C., and Fink D.J. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51 (2002) 2227-2232
33. Goss J.R., Mata M., Goins W.F., Wu H.H., Glorioso J.C., and Fink D.J. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther. 8 (2001) 551-556
34. Hao S., Mata M., Glorioso J.C., and Fink D.J. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol. Pain 2 (2006) 6
35. Zhou Z., Peng X., Hao S., Fink D.J., and Mata M. HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther. 15 (2008) 183-190
36. Mata M., Glorioso J., and Fink D.J. Development of HSV-mediated gene transfer for the treatment of chronic pain. Exp. Neurol. 184 Suppl. 1 (2003) S25-S29
37. Blits B., Oudega M., Boer G.J., Bartlett Bunge M., and Verhaagen J. Adeno-associated viral vector-mediated neurotrophin gene transfer in the injured adult rat spinal cord improves hind-limb function. Neuroscience 118 (2003) 271-281
38. Eaton M.J., Blits B., Ruitenberg M.J., Verhaagen J., and Oudega M. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther. 9 (2002) 1387-1395
39. Storek B., Harder N.M., Banck M.S., Wang C., McCarty D.M., Janssen W.G., Morrison J.H., Walsh C.E., and Beutler A.S. Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats. Mol. Pain 2 (2006) 4
40. Xu Y., Gu Y., Wu P., Li G.W., and Huang L.Y. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum. Gene Ther. 14 (2003) 897-906
41. Wolfe D., Mata M., and Fink D.J. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther. 16 (2009) 455-460